Company / Return on Assets (ROA)
Black Diamond Therapeutics, Inc. Return on Assets (ROA) History
FY2019-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-20.4%
FY2020
5-year range
-22.3% / -20.4%
FY2019-FY2020
Trend
+8.4%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-20.4% in FY2020.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2020, return on assets (roa) increased 8.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.60 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2020 | -20.4% | +8.4% |
| FY2019 | -22.3% | - |
As of FY2020 · SEC Form 10-K · Last checked Jun 21, 2026